These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 8811466)

  • 21. [Study of cases of leishmaniasis in the Province of Salta: evidences of mixed infection with Trypanosoma cruzi and Leishmania spp].
    Chiaramonte MG; Zwirner NW; Caropresi SL; Heredia V; Taranto NJ; Malchiodi EL
    Medicina (B Aires); 1996; 56(3):259-68. PubMed ID: 9035482
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epitope specificities of the group Y and W-135 polysaccharides of Neisseria meningitidis.
    Moore SL; Uitz C; Ling CC; Bundle DR; Fusco PC; Michon F
    Clin Vaccine Immunol; 2007 Oct; 14(10):1311-7. PubMed ID: 17804612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Trypanosoma cruzi: protective response of vaccinated mice is mediated by CD8+ cells, prevents signs of polyclonal T lymphocyte activation, and allows restoration of a resting immune state after challenge.
    Paiva CN; Castelo-Branco MT; Lannes-Vieira J; Gattass CR
    Exp Parasitol; 1999 Jan; 91(1):7-19. PubMed ID: 9920038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibodies against Trypanosoma cruzi alkaline antigens are elicited in sera from acute but not chronic human chagasic patients.
    Zúñiga E; Montes C; Barbieri G; Gruppi A
    Clin Immunol; 1999 Oct; 93(1):81-9. PubMed ID: 10497014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bactericidal monoclonal antibodies that define unique meningococcal B polysaccharide epitopes that do not cross-react with human polysialic acid.
    Granoff DM; Bartoloni A; Ricci S; Gallo E; Rosa D; Ravenscroft N; Guarnieri V; Seid RC; Shan A; Usinger WR; Tan S; McHugh YE; Moe GR
    J Immunol; 1998 May; 160(10):5028-36. PubMed ID: 9590252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of trypomastigotes' infectivity by a monoclonal antibody directed to a glycoconjugated fraction of epimastigotes of Trypanosoma cruzi.
    Imaz MS; Esteva M; Velázquez E; Ruiz AM; Segura EL; Marcipar AJ
    Rev Latinoam Microbiol; 1997; 39(1-2):33-46. PubMed ID: 10932713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Avidity of the immunoglobulin G response to a Neisseria meningitidis group C polysaccharide conjugate vaccine as measured by inhibition and chaotropic enzyme-linked immunosorbent assays.
    Harris SL; Tsao H; Ashton L; Goldblatt D; Fernsten P
    Clin Vaccine Immunol; 2007 Apr; 14(4):397-403. PubMed ID: 17287312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of sialic acid in the resistance of Trypanosoma cruzi trypomastigotes to complement.
    Tomlinson S; Pontes de Carvalho LC; Vandekerckhove F; Nussenzweig V
    J Immunol; 1994 Oct; 153(7):3141-7. PubMed ID: 8089492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction with host factors exacerbates Trypanosoma cruzi cell invasion capacity upon oral infection.
    Covarrubias C; Cortez M; Ferreira D; Yoshida N
    Int J Parasitol; 2007 Dec; 37(14):1609-16. PubMed ID: 17640647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specificity of humoral and cellular immune response against recombinant particles of nucleocapsid protein of human hepatitis B virus in rabbits.
    Isaguliants MG; Kadoshnikov YP; Kalinina TI; Smirnov VD; Wahren B
    Biochemistry (Mosc); 1998 May; 63(5):551-8. PubMed ID: 9632891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunization with an engineered mutant trans-sialidase highly protects mice from experimental Trypanosoma cruzi infection: a vaccine candidate.
    Fontanella GH; De Vusser K; Laroy W; Daurelio L; Nocito AL; Revelli S; Contreras R
    Vaccine; 2008 May; 26(19):2322-34. PubMed ID: 18403070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altering the motility of Trypanosoma cruzi with rabbit polyclonal anti-peptide antibodies reduces infection to susceptible mammalian cells.
    Finkelsztein EJ; Diaz-Soto JC; Vargas-Zambrano JC; Suesca E; Guzmán F; López MC; Thomas MC; Forero-Shelton M; Cuellar A; Puerta CJ; González JM
    Exp Parasitol; 2015 Mar; 150():36-43. PubMed ID: 25633439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentiation between Trypanosoma cruzi and T. rangeli by their different complement sensitivity.
    Schottelius J
    Tropenmed Parasitol; 1982 Sep; 33(3):147-50. PubMed ID: 6814023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of antigen coating conditions on enzyme-linked immunosorbent assay for detection of immunoglobulin G antibody to Neisseria meningitidis serogroup Y and W135 capsular polysaccharide antigens in serum.
    Giardina PC; Evans RE; Sikkema DJ; Madore D; Hildreth SW
    Clin Diagn Lab Immunol; 2003 Nov; 10(6):1136-40. PubMed ID: 14607879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Production of polyclonal and monoclonal antibodies against group A, B, and C capsular polysaccharides of Neisseria meningitidis and preparation of latex reagents.
    Nato F; Mazie JC; Fournier JM; Slizewicz B; Sagot N; Guibourdenche M; Postic D; Riou JY
    J Clin Microbiol; 1991 Jul; 29(7):1447-52. PubMed ID: 1909346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A radioactive antigen-binding assay for Neisseria meningitidis polysaccharide antibody.
    Brandt BL; Wyle FA; Artenstein MS
    J Immunol; 1972 Apr; 108(4):913-20. PubMed ID: 4623401
    [No Abstract]   [Full Text] [Related]  

  • 37. Immunoactivity of protein conjugates of carba analogues from Neisseria meningitidis a capsular polysaccharide.
    Gao Q; Tontini M; Brogioni G; Nilo A; Filippini S; Harfouche C; Polito L; Romano MR; Costantino P; Berti F; Adamo R; Lay L
    ACS Chem Biol; 2013 Nov; 8(11):2561-7. PubMed ID: 24000773
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative studies on surface antigenicity of Trypanosoma cruzi trypomastigotes from infected mouse blood and infected L-cell cultures.
    Kanbara H; Nakabayashi T
    Biken J; 1985 Dec; 28(3-4):71-7. PubMed ID: 3914887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production and immunochemical characterization of Neisseria meningitidis group B antiserum for the diagnosis of purulent meningitis.
    Alkmin MG; Shimizu SH; Landgraf IM; Gaspari EN; Melles CE
    Braz J Med Biol Res; 1994 Jul; 27(7):1627-34. PubMed ID: 7874029
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross-antigenicity and immunogenicity between capsular polysaccharides of group C Neisseria meningitidis and of Escherichia coli K92.
    Glode MP; Robbins JB; Liu TY; Gotschlich EC; Orskov I; Orskov F
    J Infect Dis; 1977 Jan; 135(1):94-104. PubMed ID: 64575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.